Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03395288 · ClinicalTrials.gov registry record · Phase 2
Nutraceutical Efficacy for rUTI
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
NCT03395288 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 61 participants.
The verdict
NCT03395288, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
Study Summary
This is a study designed to evaluate the efficacy of a nutraceutical as a non-antibiotic treatment to prevent recurrent urinary tract infections in women that have completed menopause and are on vaginal estrogen therapy. An additional group of women with recurrent urinary tract infections that have completed menopause but are not using vaginal estrogen therapy will be followed while taking the nutraceutical. The study length is ninety days from the date that the study participant will be instructed is day 1.
Interventions
- DRUG D-Mannose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2018-03-22 |
| Est. Completion | 2020-04-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03395288
The ClinicalTrials.gov registry entry for NCT03395288 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D-Mannose is the first listed.
NCT03395288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03395288 about?
NCT03395288 is a clinical study titled "Nutraceutical Efficacy for rUTI". This is a study designed to evaluate the efficacy of a nutraceutical as a non-antibiotic treatment to prevent recurrent urinary tract infections in women that have completed menopause and are on vaginal estrogen therapy. An additional group of women with recurrent urinary tract infections that have ...
What is the current status of trial NCT03395288?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2018-03-22. Estimated completion is 2020-04-25.
What interventions are being tested in trial NCT03395288?
The interventions under investigation include: D-Mannose (DRUG).
Who is sponsoring clinical trial NCT03395288?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.